OXT and autism: To systematically verify the necessity of the oxytocin system in the improvement of autism-like behavior by 10 Hz-pMSS, this test applied a dual pharmacological intervention strategy: the oxytocin receptor antagonist L-372662 was locally delivered to the mPFC of ASD mice through stereotaxic injection, and the function of oxytocin receptors throughout the brain was inhibited by intracerebroventricular administration.